Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

34.80p
   
  • Change Today:
    -0.100p
  • 52 Week High: 71.80
  • 52 Week Low: 34.05
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 123,374
  • Market Cap: £188.06m
  • RiskGrade: 119

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
31-Dec-18 Interim 00.00      
  Final 00.00      
31-Dec-19 Interim 0.54p 10-Jan-20 19-Dec-19 20-Dec-19
  Final 00.00      
31-Dec-20 Interim 0.54p 07-Jan-21 17-Dec-20 18-Dec-20
  Final 1.07p 08-Jul-21 10-Jun-21 11-Jun-21
31-Dec-21 Interim 0.56p 07-Jan-22 16-Dec-21 17-Dec-21
  Final 1.13p 07-Jul-22 09-Jun-22 10-Jun-22
31-Dec-22 Interim 0.59p 19-Jan-23 22-Dec-22 23-Dec-22
  Final 1.18p 18-Jul-23 22-Jun-23 23-Jun-23

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 34.80p
Change Today -0.100p
% Change -0.29 %
52 Week High 71.80
52 Week Low 34.05
Volume 123,374
Shares Issued 540.40m
Market Cap £188.06m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.31% above the market average84.31% above the market average84.31% above the market average84.31% above the market average84.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
68.22% below the market average68.22% below the market average68.22% below the market average68.22% below the market average68.22% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Income
9.89% above the market average9.89% above the market average9.89% above the market average9.89% above the market average9.89% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 26-Apr-2024

Time Volume / Share Price
15:38 477 @ 34.80p
15:38 4,999 @ 34.80p
15:38 4,808 @ 34.80p
15:38 1,082 @ 34.80p
15:37 28 @ 34.94p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page